CRISPR In Brief
Executive Summary
CRISPR/Cas9 gene editing is fast, efficient and specific. How does it work?
You may also be interested in...
CRISPR/Cas9 Patent Battle: What's Happened, What's Next?
With the gene editing pipeline at stake, academic research institutions are battling for ownership of the foundational patents in CRISPR/Cas9 technology. A new report from Datamonitor Healthcare spells out the IP challenges and provides a timeline of key patent decisions.
Can CRISPR Make The Jump To Therapeutics?
Biomedical researchers are rapidly adopting the new gene-editing technology CRISPR/Cas9 for lab experiments, but can CRISPR also become the basis for new treatments of human disease? At least two venture-backed start-ups can't wait to find out.
EU Gene Therapy Submissions, Approvals Expected To Pick Up In 2021
Coming year could feature first-time approvals in the EU for at least five gene therapies.
Need a specific report? 1000+ reports available
Buy Reports